Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
17674 | 587 | 41.7 | 88% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
268 | 3 | NEUROTROPHINS//BRAIN DERIVED NEUROTROPHIC FACTOR//BDNF | 44049 |
2405 | 2 | POLYSIALIC ACID//NCAM//NEURAL CELL ADHESION MOLECULE | 4199 |
17674 | 1 | ALCAM//CD6//CD166 | 587 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ALCAM | authKW | 2496847 | 10% | 80% | 60 |
2 | CD6 | authKW | 1024883 | 5% | 73% | 27 |
3 | CD166 | authKW | 969856 | 6% | 55% | 34 |
4 | CD72 | authKW | 432131 | 3% | 46% | 18 |
5 | ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE | authKW | 416137 | 2% | 67% | 12 |
6 | CD5 | authKW | 337560 | 8% | 14% | 46 |
7 | MOL BIOMED PATHOGENESIS | address | 233105 | 2% | 41% | 11 |
8 | APOPTOSIS INHIBITOR OF MACROPHAGE AIM | authKW | 208073 | 1% | 100% | 4 |
9 | CD5L | authKW | 208073 | 1% | 100% | 4 |
10 | NEUROLIN | authKW | 185776 | 1% | 71% | 5 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 6183 | 49% | 0% | 288 |
2 | Cell Biology | 272 | 13% | 0% | 75 |
3 | Oncology | 269 | 13% | 0% | 76 |
4 | Pathology | 123 | 5% | 0% | 28 |
5 | Medicine, Research & Experimental | 120 | 6% | 0% | 38 |
6 | Developmental Biology | 120 | 3% | 0% | 19 |
7 | Hematology | 108 | 5% | 0% | 29 |
8 | Biochemistry & Molecular Biology | 79 | 14% | 0% | 83 |
9 | Genetics & Heredity | 23 | 4% | 0% | 24 |
10 | Biophysics | 23 | 3% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL BIOMED PATHOGENESIS | 233105 | 2% | 41% | 11 |
2 | GRP IMMUNORECEPTORS SISTEMA INNAT AD TATIU | 104036 | 0% | 100% | 2 |
3 | INVEST BIOMED AUGUST PI SUNYER IDIBABS | 104036 | 0% | 100% | 2 |
4 | RAINBOW BABIES CHILDRENS HOSP 504 | 104036 | 0% | 100% | 2 |
5 | GRP CELL ACTIVAT GENE EXP S | 83224 | 1% | 40% | 4 |
6 | BIOL CELLULAR IMMUNOL NEUROCIENCIES | 65545 | 2% | 11% | 11 |
7 | ADV STUDIES VET MED | 52018 | 0% | 100% | 1 |
8 | B T UNIV MED | 52018 | 0% | 100% | 1 |
9 | BIOCHEM BIOPHYS IQUIFIBCONICET | 52018 | 0% | 100% | 1 |
10 | BIOL PHARMACOL TECH CHIYODA | 52018 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF IMMUNOLOGY | 6038 | 13% | 0% | 79 |
2 | EUROPEAN JOURNAL OF IMMUNOLOGY | 4822 | 6% | 0% | 35 |
3 | INTERNATIONAL IMMUNOLOGY | 2171 | 2% | 0% | 13 |
4 | IMMUNOGENETICS | 1664 | 2% | 0% | 12 |
5 | CRITICAL REVIEWS IN IMMUNOLOGY | 1343 | 1% | 1% | 4 |
6 | CELLULAR IMMUNOLOGY | 789 | 2% | 0% | 11 |
7 | CURRENT DRUG TARGETS | 703 | 1% | 0% | 5 |
8 | JOURNAL OF EXPERIMENTAL MEDICINE | 697 | 2% | 0% | 13 |
9 | HYBRIDOMA | 610 | 1% | 0% | 5 |
10 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY | 414 | 0% | 1% | 1 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ALCAM | 2496847 | 10% | 80% | 60 | Search ALCAM | Search ALCAM |
2 | CD6 | 1024883 | 5% | 73% | 27 | Search CD6 | Search CD6 |
3 | CD166 | 969856 | 6% | 55% | 34 | Search CD166 | Search CD166 |
4 | CD72 | 432131 | 3% | 46% | 18 | Search CD72 | Search CD72 |
5 | ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE | 416137 | 2% | 67% | 12 | Search ACTIVATED+LEUKOCYTE+CELL+ADHESION+MOLECULE | Search ACTIVATED+LEUKOCYTE+CELL+ADHESION+MOLECULE |
6 | CD5 | 337560 | 8% | 14% | 46 | Search CD5 | Search CD5 |
7 | APOPTOSIS INHIBITOR OF MACROPHAGE AIM | 208073 | 1% | 100% | 4 | Search APOPTOSIS+INHIBITOR+OF+MACROPHAGE+AIM | Search APOPTOSIS+INHIBITOR+OF+MACROPHAGE+AIM |
8 | CD5L | 208073 | 1% | 100% | 4 | Search CD5L | Search CD5L |
9 | NEUROLIN | 185776 | 1% | 71% | 5 | Search NEUROLIN | Search NEUROLIN |
10 | ALCAM CD166 | 166456 | 1% | 80% | 4 | Search ALCAM+CD166 | Search ALCAM+CD166 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SANTOS, RF , OLIVEIRA, L , CARMO, AM , (2016) TUNING T CELL ACTIVATION: THE FUNCTION OF CD6 AT THE IMMUNOLOGICAL SYNAPSE AND IN T CELL RESPONSES.CURRENT DRUG TARGETS. VOL. 17. ISSUE 6. P. 630 -639 | 61 | 69% | 2 |
2 | BROWN, MH , (2016) CD6 AS A CELL SURFACE RECEPTOR AND AS A TARGET FOR REGULATING IMMUNE RESPONSES.CURRENT DRUG TARGETS. VOL. 17. ISSUE 6. P. 619 -629 | 52 | 69% | 1 |
3 | PINTO, M , CARMO, AM , (2013) CD6 AS A THERAPEUTIC TARGET IN AUTOIMMUNE DISEASES: SUCCESSES AND CHALLENGES.BIODRUGS. VOL. 27. ISSUE 3. P. 191 -202 | 61 | 61% | 7 |
4 | XIAO, M , WANG, X , YAN, M , CHEN, WT , (2016) A SYSTEMATIC EVALUATION FOR THE POTENTIAL TRANSLATION OF CD166-RELATED EXPRESSION AS A CANCER BIOMARKER.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 16. ISSUE 9. P. 925 -932 | 45 | 73% | 0 |
5 | OFORI-ACQUAH, SF , KING, JA , (2008) ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE: A NEW PARADOX IN CANCER.TRANSLATIONAL RESEARCH. VOL. 151. ISSUE 3. P. 122-128 | 39 | 83% | 71 |
6 | KOFLER, DM , FARKAS, A , VON BERGWELT-BAILDON, M , HAFLER, DA , (2016) THE LINK BETWEEN CD6 AND AUTOIMMUNITY: GENETIC AND CELLULAR ASSOCIATIONS.CURRENT DRUG TARGETS. VOL. 17. ISSUE 6. P. 651 -665 | 69 | 41% | 1 |
7 | BONET, L , FARNOS, M , MARTINEZ-FLORENSA, M , MARTINEZ, VG , LOZANO, F , (2013) IDENTIFICATION OF FUNCTIONALLY RELEVANT PHOSHORYLATABLE SERINE CLUSTERS IN THE CYTOPLASMIC REGION OF THE HUMAN CD6 LYMPHOCYTE SURFACE RECEPTOR.FEBS LETTERS. VOL. 587. ISSUE 14. P. 2205-2213 | 27 | 100% | 2 |
8 | GIMFERRER, I , FARNOS, M , CALVO, M , MITTELBRUNN, M , ENRICH, C , SANCHEZ-MADRID, F , VIVES, J , LOZANO, F , (2003) THE ACCESSORY MOLECULES CD5 AND CD6 ASSOCIATE ON THE MEMBRANE OF LYMPHOID T CELLS.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 278. ISSUE 10. P. 8564-8571 | 40 | 74% | 35 |
9 | CHAPPELL, PE , GARNER, LI , YAN, J , METCALFE, C , HATHERLEY, D , JOHNSON, S , ROBINSON, CV , LEA, SM , BROWN, MH , (2015) STRUCTURES OF CD6 AND ITS LIGAND CD166 GIVE INSIGHT INTO THEIR INTERACTION.STRUCTURE. VOL. 23. ISSUE 8. P. 1426 -1436 | 34 | 61% | 5 |
10 | YE, M , DU, YL , NIE, YQ , ZHOU, ZW , CAO, J , LI, YF , (2015) OVEREXPRESSION OF ACTIVATED LEUKOCUTE CELL ADHESION MOLECULE IN GASTRIC CANCER IS ASSOCIATED WITH ADVANCED STAGES AND POOR PROGNOSIS AND MIR-9 DEREGULATION.MOLECULAR MEDICINE REPORTS. VOL. 11. ISSUE 3. P. 2004 -2012 | 26 | 76% | 7 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 30866 | DMBT1//SALIVARY AGGLUTININ//GP 340 |
2 | 9035 | B 1 CELLS//CD5 B CELLS//B 1A CELLS |
3 | 25567 | CD146//GICERIN//NEURITE OUTGROWTH FACTOR |
4 | 9605 | CD2//T11TS//CD58 |
5 | 22435 | SECRETOME//90K MAC 2BP//GALECTIN 3 BINDING PROTEIN |
6 | 14265 | SCAVENGER RECEPTOR//SCAVENGER RECEPTOR A//FRACTIONATED H 3HEPARIN |
7 | 9971 | L1CAM//X LINKED HYDROCEPHALUS//L1 |
8 | 12766 | SIGLEC//CD22//SIALOADHESIN |
9 | 11061 | SURFACE IGM//MEMBRANE IMMUNOGLOBULIN//IG ALPHA |
10 | 23316 | LY 6//LY 6A//LY 6A2 |